Diagnostics Pricing and Reimbursement Strategies: Overcoming Reimbursement Issues and Navigating Regulatory Environment

Reimbursement of the diagnostic testing is the key issue for both the providers and the payers. While only 5-7% of the hospital expenditures are attributed to laboratory testing, the test results are used in 70% of the healthcare decisions. This report identifies novel pricing strategies for maintaining a fair plane among all the stakeholders.

Scope

• Reviews regulatory structure in the U.S. and Europe.
• Evaluates existing pricing strategies and novel pricing strategies for healthcare diagnostic equipment.
• Presents strategic recommendations for existing and new diagnostic equipment.
• Proposes prices vs reimbursement levels for diagnostic equipment.

Contains 125 pages